AKT1 and neoplasm: The PI3K/AKT/mTOR signaling pathway plays a central role in modulating tumor radioresistance by systematically influencing tumor responses to radiotherapy through mechanisms such as DNA damage repair, cell cycle regulation, and the control of cell proliferation and apoptosis.